About ERYtech
About AGF Private Equity
AGF Private Equity, a subsidiary of the AGF Insurance Company, member of the Allianz Group, is specialized in non-listed investments. The company manages an investment portofolio close to €1,7Bn, is among the leaders in France in managing funds of funds, and is also one of the most active investors in Venture Capital. The Venture Capital team has invested in 50 high tech companies. AGF Private Equity invests €30 M each year in innovative firms. With close to €300 M under management in its Venture Capital activity, AGF Private Equity is an active partner of growth companies.
http://www.agfpe.com

About Auriga Partners
Auriga Partners is an independent venture capital firm. Based in Paris, it invests in information technologies and life sciences, in innovative high potential ventures, in seed or early development stages, in Europe, North America and Israel. Auriga Partners manages three funds for a total of more than 330 millions euros. Along with investing the necessary capital, Auriga Partners brings also its savoir-faire in developing and solidifying executive teams, organizing companies, broadening their networks and forming strategic and corporate partnerships. 
http://www.aurigapartners.com


About AXA Private Equity
AXA Private Equity, an AXA Investment Managers company, with offices in Paris, Frankfurt, London, New York and Singapore, is a world leader in Private Equity players covering the whole range of activities (LBO, Expansion, Venture, Co-investment, Mezzanine, Primary, Early Secondary and Secondary Funds of Funds) with an exceptional expertise.
AXA Private Equity manages and/or advises Private Equity funds with assets in excess of €10 billion for some of the world’s leading investors. With a constant focus on transparency, performance and sustainable profitability, AXA Private Equity is supported by the expertise of its staff and its international experience.
http://www.axaprivateequity.fr


About Capdecisif
CapDecisif is an early stage venture firm dedicated to investing in high potential, high innovation companies. CapDecisif was created in 2001, manages around €18 M and is supported among others by CDC Entreprises and Natexis Group as well as the Paris Ile-de-France Region. It has 17 portfolio companies in Information Technologies and Life Sciences.
Jérome Snollaerts +33 1 75 00 01 00
http://www.capdecisif.com


About Amorçage Rhône Alpes
Created in 2002, Amorçage Rhône Alpes is an early stage venture fund whose aim is to help young and innovative high technologies companies located in the Rhône Alpes region. With €5.6M managed and 15 investments already achieved, Amorçage Rhône Alpes is active in Information Technologies, Biotechnologies and other industries. Amorçage Rhône Alpes Sharelholders include the Rhône Alpes Region, CDC entreprises as well as local banks and funds. Erytech is the forth of our investments concluding its second funding.
Karine Lignel : +33 4 72 52 39 52
http://www.a-r-a.fr

For more information on investors’ relations, please contact us using our Contact details.

 

Erytech Pharma
Last Update 12/11/2008
2005 ERYtech Inc. All Rights Reserved | Terms and Conditions | Contact Us